ABEONA THERAPEUTICS INC. (ABEO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 4M 8M 12M Q2 '10: 102K Q2 '10: 105K Q3 '10: 127K Q4 '10: 147K Q1 '11: 150K Q2 '11: 150K Q2 '11: 151K Q3 '11: 1M Q4 '11: 498K Q1 '12: 1.8M Q2 '12: 690K Q3 '12: 871K Q4 '12: 1M Q1 '13: 1.2M Q2 '13: 467K Q3 '13: 189K Q4 '13: 162K Q1 '14: 208K Q2 '14: 247K Q3 '14: 236K Q4 '14: 234K Q1 '15: 258K Q2 '15: 282K Q3 '15: 285K Q4 '15: 215K Q1 '16: 235K Q2 '16: 214K Q3 '16: 184K Q4 '16: 256K Q1 '17: 186K Q2 '17: 217K Q3 '17: 219K Q4 '17: 215K Q1 '18: 531K Q2 '18: 276K Q3 '18: 1.7M Q4 '18: 482K Q1 '19: 0 Q2 '19: 0 Q3 '20: 7M Q4 '20: 3M Q1 '22: 346K Q2 '22: 1M Q3 '22: 0 Q4 '22: 68K Q1 '23: 0 Q2 '23: 3.5M Q3 '23: 0 Q4 '23: 0 Q1 '25: 0 Q2 '25: 400K Q3 '25: 0 Q4 '25: 5.4M Q1 '26: 8.7M Q2 '26: 11.4M Q2 '11 Q4 '12 Q3 '14 Q2 '16 Q1 '18 Q4 '20 Q3 '23 Q2 '26

Gross Profit Quarterly

-2.5M 0 2.5M 5M 7.5M Q3 '25: -488K Q4 '25: 4.4M Q1 '26: 6M Q2 '26: 7.2M Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '11: -2.1M Q2 '11: -2.3M Q3 '11: -1.8M Q4 '11: -1.7M Q1 '12: -689K Q2 '12: -1.5M Q3 '12: -956K Q4 '12: -1.2M Q1 '13: -503K Q2 '13: -1.9M Q3 '13: -696K Q4 '13: -684K Q1 '14: -1.3M Q2 '14: -703K Q3 '14: -633K Q4 '14: -467K Q1 '15: -2M Q2 '15: -4.1M Q3 '15: -6.2M Q4 '15: -6.3M Q1 '16: -6.2M Q2 '16: -6.7M Q3 '16: -5.2M Q4 '16: -5.8M Q1 '17: -5.3M Q2 '17: -8.4M Q3 '17: -5.4M Q4 '17: -8.8M Q1 '18: -10.7M Q2 '18: -12.6M Q3 '18: -16.9M Q4 '18: -18M Q1 '19: -19.1M Q2 '19: -24M Q3 '19: -17.6M Q4 '19: -16.4M Q1 '20: -48.2M Q2 '20: -12.5M Q3 '20: -6.2M Q4 '20: -14.5M Q1 '21: -14.6M Q2 '21: -13.7M Q3 '21: -14.9M Q4 '21: -46.7M Q1 '22: -20.6M Q2 '22: -8M Q3 '22: -9.4M Q4 '22: -12.9M Q1 '23: -12M Q2 '23: -10.6M Q3 '23: -11.3M Q4 '23: -13.2M Q1 '24: -14.3M Q2 '24: -17.9M Q3 '24: -15.3M Q4 '24: -16.7M Q1 '25: -19.7M Q2 '25: -22.8M Q3 '25: -24M Q4 '25: -22.9M Q1 '26: -23M Q2 '26: -13.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-80M -40M 0 40M 80M 120M Q2 '10: 1.8M Q3 '10: -12.7M Q1 '11: -1.9M Q2 '11: -1.3M Q2 '11: -1.3M Q3 '11: 350K Q4 '11: -166K Q1 '12: -4.9M Q2 '12: -10.6M Q3 '12: -14.9M Q4 '12: 19.8M Q1 '13: 4.1M Q2 '13: 1.6M Q3 '13: -157K Q4 '13: -1.1M Q1 '14: -859K Q2 '14: -12.5M Q3 '14: -1.5M Q4 '14: -11.9M Q1 '15: -2M Q2 '15: -4.1M Q3 '15: -6.1M Q4 '15: -2.3M Q1 '16: -5.5M Q2 '16: -6.7M Q3 '16: -2.6M Q4 '16: -7M Q1 '17: -5.2M Q2 '17: -8.3M Q3 '17: -5.3M Q4 '17: -8.4M Q1 '18: -10.5M Q2 '18: -12.2M Q3 '18: -16.4M Q4 '18: -17.5M Q1 '19: -18.6M Q2 '19: -23.9M Q3 '19: -17.4M Q4 '19: -16.4M Q1 '20: -48.2M Q2 '20: -13M Q3 '20: -7.2M Q4 '20: -15.8M Q1 '21: -16M Q2 '21: -15.2M Q3 '21: -7M Q4 '21: -46.7M Q1 '22: -22M Q2 '22: -4.1M Q3 '22: -6.4M Q4 '22: -7.1M Q1 '23: -9.1M Q2 '23: -16.7M Q3 '23: -11.8M Q4 '23: -16.6M Q1 '24: -31.6M Q2 '24: 7.4M Q3 '24: -30.3M Q4 '24: -9.3M Q1 '25: -12M Q2 '25: 108.8M Q3 '25: -5.2M Q4 '25: -20.5M Q1 '26: -17.1M Q2 '26: -20.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '25: 488K Q4 '25: 1M Q1 '26: 2.7M Q2 '26: 4.2M Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '10: -1.3M Q4 '10: -1.7M Q1 '11: -837K Q2 '11: -1.8M Q3 '11: -3M Q4 '11: -2M Q1 '12: -1.1M Q2 '12: -775K Q3 '12: -482K Q4 '12: -1.6M Q1 '13: -346K Q2 '13: 1.7M Q3 '13: -916K Q4 '13: -474K Q1 '14: -125K Q2 '14: -244K Q3 '14: -140K Q4 '14: -1.1M Q1 '15: -3.2M Q2 '15: -1.9M Q3 '15: -2.5M Q4 '15: -2.9M Q1 '16: -2.5M Q2 '16: -3.1M Q3 '16: -4M Q4 '16: -3.4M Q1 '17: -5.9M Q2 '17: -5M Q3 '17: -6.8M Q4 '17: -5M Q1 '18: -4.1M Q2 '18: -9M Q3 '18: -9M Q4 '18: -17M Q1 '19: -15.1M Q2 '19: -15.2M Q3 '19: -18.3M Q4 '19: -14.2M Q1 '20: -13.2M Q2 '20: -9.5M Q3 '20: -10.7M Q4 '20: -1.6M Q1 '21: -13.6M Q2 '21: -11.5M Q3 '21: -10.3M Q4 '21: -30.3M Q1 '22: -13.7M Q2 '22: -9M Q3 '22: -6.8M Q4 '22: -14M Q1 '23: -11.7M Q2 '23: -10.3M Q3 '23: -5.7M Q4 '23: -9.2M Q1 '24: -14.5M Q2 '24: -12.7M Q3 '24: -12.2M Q4 '24: -16.6M Q1 '25: -18.4M Q2 '25: -18.8M Q3 '25: -21.2M Q4 '25: -18M Q1 '26: -19.8M Q2 '26: -17.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '10: -1.3M Q1 '11: -859K Q2 '11: -1.8M Q3 '11: -3M Q4 '11: -2M Q1 '12: -1.1M Q2 '12: -777K Q3 '12: -482K Q4 '12: -1.6M Q1 '13: -346K Q2 '13: 1.7M Q3 '13: -917K Q4 '13: -475K Q1 '14: -125K Q2 '14: -244K Q3 '14: -140K Q4 '14: -1.1M Q1 '15: -3.2M Q2 '15: -1.9M Q3 '15: -2.5M Q4 '15: -3.1M Q1 '16: -2.7M Q2 '16: -3.2M Q3 '16: -4.1M Q4 '16: -3.4M Q1 '17: -5.9M Q2 '17: -5M Q3 '17: -6.8M Q4 '17: -5.8M Q1 '18: -7.6M Q2 '18: -12.4M Q3 '18: -10.7M Q4 '18: -17.6M Q1 '19: -16.3M Q2 '19: -19.3M Q3 '19: -19.2M Q4 '19: -14.4M Q1 '20: -13.7M Q2 '20: -10M Q3 '20: -11M Q4 '20: -1.6M Q1 '21: -14M Q2 '21: -11.5M Q3 '21: -10.7M Q4 '21: -33.5M Q1 '22: -13.8M Q2 '22: -9M Q3 '22: -6.8M Q4 '22: -14M Q1 '23: -12M Q2 '23: -10.3M Q3 '23: -5.8M Q4 '23: -9.3M Q1 '24: -15.3M Q2 '24: -13.4M Q3 '24: -12.6M Q4 '24: -17.2M Q1 '25: -19.8M Q2 '25: -21.7M Q3 '25: -23.7M Q4 '25: -19.1M Q1 '26: -20.7M Q2 '26: -18M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '10: 27.9M Q1 '11: 19.2M Q2 '11: 19.4M Q1 '12: 24.1M Q2 '12: 24.2M Q3 '12: 24.2M Q1 '13: 25.2M Q2 '13: 25.5M Q3 '13: 508.7K Q1 '14: 25.9M Q2 '14: 26.2M Q3 '14: 532.3K Q1 '21: 94.2M Q2 '21: 3.9M Q3 '21: 3.9M Q1 '22: 5.8M Q2 '22: 5.8M Q3 '22: 6.4M Q1 '23: 16.9M Q2 '23: 18M Q3 '23: 24.8M Q1 '24: 27.3M Q2 '24: 51.2M Q3 '24: 48.1M Q1 '25: 49.8M Q2 '25: 66.6M Q3 '25: 54.2M Q1 '26: 56.6M Q2 '26: 57M Q2 '10 Q2 '12 Q3 '13 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q1 '12: -0.32 Q2 '12: -0.69 Q3 '12: -1.32 Q4 '12: -0.52 Q1 '13: -0.17 Q2 '13: 0.32 Q4 '15: -0.51 Q1 '16: -0.58 Q2 '16: -0.62 Q3 '16: -0.51 Q4 '16: -0.64 Q1 '17: -0.60 Q2 '17: -0.61 Q3 '17: -0.66 Q4 '17: -0.66 Q1 '18: -0.75 Q2 '18: -0.80 Q3 '18: -1.01 Q4 '18: -1.18 Q1 '19: -1.35 Q2 '19: -1.58 Q3 '19: -1.59 Q4 '19: -1.53 Q1 '20: -1.66 Q2 '20: -1.31 Q3 '20: -1.04 Q4 '20: -0.91 Q1 '21: -0.56 Q3 '22: -3.90 Q4 '22: -5.53 Q1 '23: -2.27 Q2 '23: -4.55 Q3 '23: -4.03 Q4 '23: -2.58 Q1 '24: -3.20 Q2 '24: -2.54 Q3 '24: -2.69 Q4 '24: -2.19 Q1 '25: -1.27 Q2 '25: 0.70 Q3 '25: 1.23 Q4 '25: 1.01 Q1 '26: 0.95 Q2 '26: -1.11 Q2 '12 Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.